GARVAN INSTITUTE OF MEDICAL RESEARCH

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: -

Established: 1963-01-01

Employees: -

Market Cap: -

Website: http://www.garvan.org.au

Clinical Trials

Preventing Cognitive Decline with Metformin

Phase 3

Active, not recruiting

Conditions: Cognitive Decline

Interventions: Drug: Metformin XR, 500-2000mg nocte

First Posted Date: 2020-08-13

Last Posted Date: 2024-10-02

Lead Sponsor: Garvan Institute of Medical Research

Target Recruit Count: 242

Registration Number: NCT04511416

Locations: 🇦🇺
Garvan Institute of Medical Research, Sydney, New South Wales, Australia

Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes

Not Applicable

Completed

Conditions: Pre Diabetes
Type 2 Diabetes Mellitus

Interventions: Drug: Metformin + Healthy diet
Drug: Metformin + Personalized diet

First Posted Date: 2018-06-15

Last Posted Date: 2024-10-31

Lead Sponsor: Garvan Institute of Medical Research

Target Recruit Count: 138

Registration Number: NCT03558867

Locations: 🇦🇺
Garvan Institute of Medical Research, Sydney, New South Wales, Australia

Optimising Health in Type 1 Diabetes

Not Applicable

Completed

Conditions: Diabetes Mellitus

Interventions: Other: Novel diet
Other: Standard diet

First Posted Date: 2016-09-16

Last Posted Date: 2022-03-22

Lead Sponsor: Garvan Institute of Medical Research

Target Recruit Count: 13

Registration Number: NCT02903615

Locations: 🇦🇺
Garvan Institute to Medical Research, Sydney, Australia
🇦🇺
professor Katherine Samaras, Sydney, New South Wales, Australia

Alkaline Diet for Insulin Sensitivity

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus
Dysglycemia

Interventions: Drug: Sodium Bicarbonate Oral Capsule
Drug: Placebo

First Posted Date: 2015-07-17

Last Posted Date: 2017-03-07

Lead Sponsor: Garvan Institute of Medical Research

Target Recruit Count: 32

Registration Number: NCT02501343

Locations: 🇦🇺
Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia

Insulin-sensitive Obesity: Lessons From Longitudinal Data

Completed

Conditions: Insulin Sensitivity/Resistance
Obesity

First Posted Date: 2013-12-20

Last Posted Date: 2020-02-24

Lead Sponsor: Garvan Institute of Medical Research

Target Recruit Count: 57

Registration Number: NCT02017210

Locations: 🇦🇺
Dorit Samocha-Bonet, Darlinghurst, New South Wales, Australia

Chronic Hepatitis C and Insulin Resistance

Completed

Conditions: Hepatitis C
Insulin Resistance

First Posted Date: 2008-07-01

Last Posted Date: 2015-07-14

Lead Sponsor: Garvan Institute of Medical Research

Target Recruit Count: 50

Registration Number: NCT00707603

Locations: 🇦🇺
Garvan Institute Of Medical Research, Sydney, New South Wales, Australia
🇦🇺
Storr Liver Unit, Sydney, New South Wales, Australia

Effects of Glutamine on GLP-1 and Insulin Secretion in Man

Not Applicable

Completed

Conditions: Type 2 Diabetes

Interventions: Drug: Placebo
Drug: Sitagliptin

First Posted Date: 2008-05-07

Last Posted Date: 2019-05-13

Lead Sponsor: Garvan Institute of Medical Research

Target Recruit Count: 22

Registration Number: NCT00673894

Locations: 🇦🇺
Clinical Research Facility, Sydney, New South Wales, Australia

Effects of Medical and Surgical Weight Loss on Metabolism

Completed

Conditions: Obesity
Type 2 Diabetes

Interventions: Procedure: laparoscopic gastric banding

First Posted Date: 2008-01-14

Last Posted Date: 2016-06-07

Lead Sponsor: Garvan Institute of Medical Research

Target Recruit Count: 20

Registration Number: NCT00592735

Locations: 🇦🇺
St Vincent's Hospital, Sydney, New South Wales, Australia

Effects of Excess Energy Intake on Metabolic Risk

Not Applicable

Completed

Conditions: Insulin Resistance

Interventions: Other: Nutritional

First Posted Date: 2007-11-22

Last Posted Date: 2015-07-14

Lead Sponsor: Garvan Institute of Medical Research

Target Recruit Count: 41

Registration Number: NCT00562393

Locations: 🇦🇺
Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia

Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome

Not Applicable

Completed

Conditions: Prader-Willi Syndrome

Interventions: Drug: Exenatide

First Posted Date: 2007-10-30

Last Posted Date: 2020-07-07

Lead Sponsor: Garvan Institute of Medical Research

Target Recruit Count: 20

Registration Number: NCT00551343

Locations: 🇦🇺
Garvan Institute of Medical Research, Sydney, New South Wales, Australia

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy